1 王玲,张振安,李树英,等. 硫酸头孢喹肟的合成方法: CN 102002058A.2011-04-06. 2 张许科,刘兴金,张永奎,等.一种制备硫酸头孢喹诺的方法:CN 101108858A.2008-01-23. 3 李长青,崔增学. 硫酸头孢喹肟的制备方法: CN 101307064A.2008-11-19. 4 李常青,闫祥华,薛俊娟,等. 硫酸头孢喹肟的合成[J].应用化工,2008,37(2):231~232. 5 杜向党,李新生,吴宇鹏,等.头孢喹诺的最新研究进展[J].中国畜牧兽医,2006,33(9):15~17. 6 杨美丽,郑国钧. 硫酸头孢喹诺的合成[J].化学试剂,2008,30(10):787~788. 7 辛海红,范中元. 头孢噻肟酸合成母液回收工艺的研究[J].黑龙江医药,2004,17(2):121~122. 8 邵意阳,屈一新,任慧. 硫酸头孢喹肟的合成[J].中国医药工业杂志,2007,38(6):405~406. 9 洪玲娟,郑叶敏,汤有坚,等. 头孢噻肟酸的环境友好合成工艺[J].浙江化工,2010,41(3):15~17. 10 荣俊,张军忍,余祖功,等. 国产硫酸头孢喹肟对小鼠的急性和蓄积毒性研究[J]. 动物医学进展,2008,29(2):48~51. 11 赵德明,竺三奇,费可方,等.头孢噻肟酸的合成研究[J]. 浙江工业大学学报,2010,38(1):7~10. 12 钟为慧,洪玲娟,汤有坚,等. 一种头孢噻肟酸的绿色合成方法: CN 101550149A. 2009-10-07. 13 谢英新,陈玉山,崔嵘,等.一种头孢噻肟的制备方法:CN 101613360A. 2009-08-07. 14 Aarestrup F M, Skov R L. Evaluation of ceftiofur and cefquinome for phenotypic detection of methicillin resistance in Staphylococcus aureus using disk diffusion testing and MIC-determinations. Veterinary Microbiology,2010,140(1~2):176~179. 15 Aurich C, Spergser J. Influence of bacteria and gentamicin on cooled-stored stallion spermatozoa. Theriogenology, 2007, 67(5):912~918. 16 Bottner A, Schmid P, Humke R. In vitro efficacy of cefquinome (INN) and other anti-infective drugs against bovine bacterial isolates from Belgium, France, Germany, the Netherlands, and the United Kingdom. Zentralbl Veterinarmed B,1995,42(6):377~386. 17 Bradley A J, Green M J. Factors affecting cure when treating bovine clinical mastitis with cephalosporin-based intramammary preparations. Journal of Dairy Science, 2009, 92(5):1941~1953. 18 Cerniglia C E, Kotarski S. Approaches in the safety evaluations of veterinary antimicrobial agents in food to determine the effects on the human intestinal microflora. Journal of Veterinary Pharmacology and Therapeutics,2005,28(1):3~20. 19 Chin N X, Gu J W, Fang W, et al. In vitro activity of cefquinome, a new cephalosporin, compared with other cephalosporin antibiotics.Diagn Microbiol Infect Dis,1992,15(4):331~337. 20 Deshpande P B, Deshpande P N, Srinivasan S, et al. Thioester derivatives of thiazolyl acetic acid and their use in the preparation of cephalosporin of cephalosporin compounds: US 6610845.2003-08-26. 21 Ehinger A M, Schmidt H, Kietzmann M. Tissue distribution of cefquinome after intramammary and "systemic" administration in the isolated perfused bovine udder. The Veterinary Journal, 2006,172(1):147~153. 22 Guerin-Faublee V, Carret G, Houffschmit P. In vitro activity of antimierobial 10 antimicrobial agents against bacteria isolated from cows with clincalmastitis. The Veterinary Record,2003,152(15):466~471. 23 Kang T W, Lee H W, Cha K H, et al. Diethyl chlorophosphate: An effective and convenient coupling reagent of cephalosporin derivatives. Synth Commun,1998,28:35~44. 24 Khanna J M, Handa V K, Dandala R, et al. Process for producing cephalosporin antibiotics: US 5869649.1999-02-09. 25 Knappstein K, Suhren G, Walte H G. Influence of milking frequency on withdrawal period after application of lactam antibiotic-based drugs. Analytica Chimica Acta,2003,483(1):241~249. 26 Lang I, Rose M, Thoms E. A field study of cefquinome for the treatment of pigs with respiratory disease. Revue de Medicine Veterinaire,2002,153(8~9):575~578. 27 Limbert M, Isert D, Klesel N, et al. Antibacterial activities in vitro and in vivo and pharmacokinetics of cefquinome (HR 111V), a new broad-spectrum cephalosporin. Antimicrobial Agents and Chemotherapy,1991,35(1):14~19. 28 Macher. Production of cefotaxime and new sodium salts: WO 9620198.1996-07-04. 29 Melnikow E, Schoenfeld C, Spehr V, et al. A compendium of antibiotic-induced transcription profiles reveals broad regulation of Pasteurella multocida virulence genes. Veterinary Microbiology,2008,131(1~3):277~292. 30 Murphy S P, Erwin M E, Jones R N. Cefquinome (HR 111V). In vitro evaluation of a broad-spectrum cephalosporin indicated for infections in animals. Diagnostic Microbiology and Infectious Disease,1994,20(1):49~55. 31 Parlevliet J M, Lynn J W, Paccamonti D L. The use of cefquinome in equine semen extender. Journal of Equine Veterinary Science,2011,31(3):139~142. 32 Pejsak Z, Kolodziejezyk P. Incidence and drug sensitivity of bacterial isolated form diseased lungs in pigs. Medyeyna Weterynaryjna,2001,57:7480~7485. 33 Pengov A. Treament of clinical and subclinical mastitis cases with Gobactan. Veterinarske Novice(Slovenia), 2001, 27(4):145~148. 34 Rudolf L, Taunus K, Walter D, et al. Crystallized cephem-acid addition salts, and a pross for the preparation thereof: US 4845087.1989-07-04. 35 Shpigel N Y, Schmid P. Contribution to the treatment of acute bovine mastitis with cefquinome. Tierarztliche Praxis,1997a,25(3):200~206. 36 Shpigel N Y, Levin D, Winkler M,et al. Efficacy of cefquinome for treatment of cows with mastitis experimentally induced using Escherichia coli. Journal of Dairy Science,1997b,80(2):318~323. 37 Sørensen L K, Snor L K. Determination of cephalosporins in raw bovine milk by high-performance liquid chromatography. Journal of Chromatography A, 2000,882(1):145~151. 38 Suhren G, Knappstein K. Detection of cefquinome in milk by liquid chromatography and screening methods. Analytica Chimica Acta,2003,483(1): 363~372. 39 Sung K L, Soon K M, Gwan S L. Process for preparing cephem derivatives: EP 0175814. 1986-02-04. 40 Thomas E, Thomas V, Wilhelm C. Antibacterial activity of cefquinome against equine bacterial pathogens. Veterinary Microbiology,2006,115(1~3):140~147. 41 Uney K, Altan F, Elmas M. Development and validation of a high-performance liquid chromatography method for determination of cefquinome concentrations in sheep plasma and its application to pharmacokinetic studies. Antimicrobisal Agents And Chemotherapy, 2011, 55(2):854~859. 42 Wilfried S, Walter D, Reiner K, et al. Process for the preparation of cephem compounds: US 4667028.1987-05-19. |